Literature DB >> 30783968

Quantitative and Digital Droplet-Based AAV Genome Titration.

Julio Sanmiguel1,2, Guangping Gao3,4,5, Luk H Vandenberghe6,7,8,9.   

Abstract

The adeno-associated viral vector (AAV) platform has developed into a primary modality for efficient in vivo, and in more limited settings, in vitro or ex vivo gene transfer. Its applications range from a tool for experimental purposes to preclinical and clinical gene therapy. The ability to accurately and reproducibly quantify vector concentration is critical for any of these applications. While several quantification assays are available, here we outline a detailed protocol for the quantification of DNase-I protected vector genomes reliant on the polymerase chain reaction (PCR) as a measure of the active component of the vector, namely its transgene cargo. With the emergence of droplet digital PCR (ddPCR), we provide side-by-side protocols for traditional TaqMan™ real-time, quantitative PCR (qPCR) and ddPCR, as well as comparative data generated with both methods. Lastly, we discuss the importance of the use of surfactant (here, Pluronic® F-68) in the execution of the assay to limit DNA and AAV adherence to various carriers during the titration, particularly at low concentrations. We believe these protocols can lead to reduced variability and increased comparability between AAV studies.

Entities:  

Keywords:  AAV; Adeno-associated virus; Droplet digital PCR; Genome; Quantitative PCR; Real-time PCR; Titration; Vector; ddPCR; qPCR

Mesh:

Year:  2019        PMID: 30783968     DOI: 10.1007/978-1-4939-9139-6_4

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  7 in total

1.  AAV6 Is Superior to Clade F AAVs in Stimulating Homologous Recombination-Based Genome Editing in Human HSPCs.

Authors:  Amanda M Dudek; Matthew H Porteus
Journal:  Mol Ther       Date:  2019-09-12       Impact factor: 11.454

2.  Immunogenicity of an AAV-Based COVID-19 Vaccine in Murine Models of Obesity and Aging.

Authors:  Dawid Maciorowski; Cheikh Diop; Urja Bhatt; Reynette Estelien; Dan Li; Ruchi Chauhan; Luk H Vandenberghe; Nerea Zabaleta
Journal:  Viruses       Date:  2022-04-15       Impact factor: 5.818

Review 3.  Analytical methods to characterize recombinant adeno-associated virus vectors and the benefit of standardization and reference materials.

Authors:  Erica A Green; Kelvin H Lee
Journal:  Curr Opin Biotechnol       Date:  2021-07-15       Impact factor: 10.279

4.  A Generic Method for Fast and Sensitive Detection of Adeno-Associated Viruses Using Modified AAV Receptor Recombinant Proteins.

Authors:  Mengtian Cui; Yabin Lu; Can Tang; Ran Zhang; Jing Wang; Yang Si; Shan Cheng; Wei Ding
Journal:  Molecules       Date:  2019-11-03       Impact factor: 4.411

5.  Differential T cell immune responses to deamidated adeno-associated virus vector.

Authors:  So Jin Bing; Sune Justesen; Wells W Wu; Abdul Mohin Sajib; Stephanee Warrington; Alan Baer; Stephan Thorgrimsen; Rong-Fong Shen; Ronit Mazor
Journal:  Mol Ther Methods Clin Dev       Date:  2022-01-18       Impact factor: 6.698

6.  A pilot study of neonatal GALT gene replacement using AAV9 dramatically lowers galactose metabolites in blood, liver, and brain and minimizes cataracts in GALT-null rat pups.

Authors:  Shauna A Rasmussen; Jennifer M I Daenzer; Judith L Fridovich-Keil
Journal:  J Inherit Metab Dis       Date:  2020-09-17       Impact factor: 4.982

Review 7.  PCR-Based Analytical Methods for Quantification and Quality Control of Recombinant Adeno-Associated Viral Vector Preparations.

Authors:  Anna A Shmidt; Tatiana V Egorova
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.